Association of Breastfeeding and Neonatal Jaundice With Infant Neurodevelopment

Kang Ke1, Xia Chi2, Hong Lv3

  • 1State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu, China; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.

Insights

Exclusive breastfeeding benefits infant neurodevelopment. Continuing exclusive breastfeeding for infants with severe neonatal jaundice is recommended to support cognitive and fine motor skill development.

Area of Science:

  • Pediatrics
  • Neurodevelopmental Pediatrics
  • Neonatology

Background:

  • Exclusive breastfeeding is recognized for its advantages in infant neurodevelopment.
  • Neonatal jaundice, particularly severe cases, poses a risk to neurological development.
  • The optimal breastfeeding strategy for infants with neonatal jaundice is not well-defined.

Purpose of the Study:

  • To investigate the association between breastfeeding status, neonatal jaundice, and infant neurodevelopment.
  • To determine if exclusive breastfeeding should be continued in infants diagnosed with neonatal jaundice.

Main Methods:

  • Utilized data from the prospective Jiangsu Birth Cohort (JBC) study.
  • Included 2,577 infants born between November 2017 and March 2021.
  • Employed multivariate linear regression models to analyze associations and interactions.

Main Results:

  • Exclusive breastfeeding was linked to higher fine motor scores compared to mixed or no breastfeeding.
  • Severe neonatal jaundice was associated with lower cognitive and fine motor scores.
  • Discontinuing exclusive breastfeeding before 6 months in infants with severe jaundice correlated with poorer cognitive outcomes.

Conclusions:

  • Exclusive breastfeeding for the initial six months supports infant neurodevelopment.
  • Maintaining exclusive breastfeeding is particularly crucial for infants experiencing severe neonatal jaundice to mitigate potential neurological harm.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
173
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
315